Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxis

18 Jun 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40543515
DOI: 10.1016/s2352-3018(25)00128-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxisPMID 40543515Read ↗

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysisSemantic proximity Read ↗

Overview on HIV-1-related drug resistance: from theory to clinical practice.Semantic proximity Read ↗

Pharmacokinetics, pharmacodynamics, efficacy and drug resistance selection of injectable long-acting lenacapavir pre-exposure prophylaxis (PrEP) against HIVSemantic proximity Read ↗

HIV drug resistance.Semantic proximity Read ↗

Drug resistance in HIV-1Semantic proximity Read ↗

Recent progress in antiretrovirals – lessons from resistanceSemantic proximity Read ↗

Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.Semantic proximity Read ↗

HIV drug resistance and you. Resistance overview. A look at the basics.Semantic proximity Read ↗

Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 YearsSemantic proximity Read ↗

Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome.Semantic proximity Read ↗

Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimensSemantic proximity Read ↗

Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.